In this study, we evaluated the impact of MYC on HNSCC’s response to trametinib, specifically exploring the hypersensitivity conferred by MYC overexpression to trametinib in HNSCC cells. This evidence concerns the gene MYC and head and neck squamous cell carcinoma.